gene

SLC31A2

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SLC31A2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

8Connections
0Hypotheses
0Analyses
6Outgoing
2Incoming
0Experiments
0Debates

Summary

Page for SLC31A2 — Solute Carrier Family 3 Member 1A2 (SLC31A2)

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolSLC31A2
Full NameSolute Carrier Family 3 Member 1A2 (SLC31A2)
Chromosome9q32
Primary Expressionvarious tissues and plays complementary roles in copper acquisition, particularly in tissues where CTR1 expression is low or under conditions of high
UniProt IDO15432
NCBI Gene ID10552
Ensembl IDENSG00000137573
OMIM603086
GeneCardsSLC31A2
Human Protein AtlasSLC31A2
CTR1Dominates copper uptake at low extracellular copper concentrations
CTR2Becomes more important when copper concentrations are elevated [@affinity]
Associated DiseasesAls, Atherosclerosis
KG Connections8 knowledge graph edges
DatabasesGeneCardsHPASTRING
🔮 Predicted Structure: SLC31A2 — AlphaFold O15432 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

SLC31A2 — Solute Carrier Family 3 Member 1A2 (SLC31A2)

gene · 691 words

Pathway Diagram

flowchart TD
    N0["SLC31A2"]
    N1["Als"]
    N0 -->|"associated with"| N1
    N2["Atherosclerosis"]
    N0 -->|"associated with"| N2
    N3["RAB23"]
    N0 -->|"associated with"| N3
    N4["CDKN2A"]
    N0 -->|"regulates"| N4
    N5["GLS"]
    N0 -->|"regulates"| N5
    N6["Actin"]
    N0 -->|"associated with"| N6
    N7["SGCE"]
    N7 -->|"associated with"| N0
    N8["NLRP3"]
    N8 -->|"regulates"| N0
    N9["neurodegeneration"]
    N0 -->|"implicated in"| N9

    classDef gene fill:#1a3a2a,stroke:#4caf50,color:#e0e0e0
    classDef protein fill:#1a2a3a,stroke:#4fc3f7,color:#e0e0e0
    classDef disease fill:#3a1a1a,stroke:#ef5350,color:#e0e0e0
    classDef pathway fill:#2a1a3a,stroke:#ce93d8,color:#e0e0e0
    classDef mechanism fill:#2a2a1a,stroke:#ffd54f,color:#e0e0e0
    class N1 disease
    class N2 disease
    class N3 gene
    class N4 gene
    class N5 gene
    class N6 protein
    class N7 gene
    class N8 gene

Outgoing (6)

TargetRelationTypeStr
Alsassociated_withdisease0.65
Atherosclerosisassociated_withdisease0.65
Actinassociated_withprotein0.60
RAB23associated_withgene0.60
CDKN2Aregulatesgene0.60

Incoming (2)

SourceRelationTypeStr
SGCEassociated_withgene0.60
NLRP3regulatesgene0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning SLC31A2 in their description or question text

No additional research found